No. of Pages: 105 | Report Code: TIPRE00025159 | Category: Life Sciences
1.1 Report Guidance
1.2 Market Segmentation
2.1 Key Insights
2.2 Market Attractiveness
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4.1 Market Drivers
4.1.1 Growing Emphasis on Better Treatment Outcomes
4.1.2 Increasing Preference for Healthcare Cost Optimization
4.2 Market Restraints
4.2.1 Lack of Awareness and Reluctance Toward Adoption of Medical Second Opinion in Emerging Nations
4.3 Market Opportunities
4.3.1 Rising Collaborations in Telemedicine Technologies
4.4 Future Trends
4.4.1 Digitalization of Medical Consulting Services
4.5 Impact of Drivers and Restraints:
5.1 North America Medical Second Opinion Market Revenue (US$ Million), 2021–2031
5.2 North America Medical Second Opinion Market Forecast Analysis
6.1 Cancer
6.1.1 Overview
6.1.2 Cancer: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.2 Orthopedic Disorders
6.2.1 Overview
6.2.2 Orthopedic Disorders: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.3 Cardiac Disorders
6.3.1 Overview
6.3.2 Cardiac Disorders: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.4 Neurological Disorders
6.4.1 Overview
6.4.2 Neurological Disorders: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.5 Nephrological Disorders
6.5.1 Overview
6.5.2 Nephrological Disorders: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.6 Hematological Blood Disorders
6.6.1 Overview
6.6.2 Hematological Blood Disorders: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.7 COPD
6.7.1 Overview
6.7.2 COPD: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.8 Organ Transplant
6.8.1 Overview
6.8.2 Organ Transplant: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
6.9 Others
6.9.1 Overview
6.9.2 Others: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
7.1 Hospitals
7.1.1 Overview
7.1.2 Hospitals: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
7.2 Health Insurance Companies
7.2.1 Overview
7.2.2 Health Insurance Companies: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
7.3 Online Services
7.3.1 Overview
7.3.2 Online Services: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
8.1 North America
8.1.1 North America Medical Second Opinion Market Overview
8.1.2 North America Medical Second Opinion Market – Revenue and Forecast Analysis – by Country
8.1.2.1 North America Medical Second Opinion Market – Revenue and Forecast Analysis – by Country
8.1.2.2 United States: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
8.1.2.2.1 United States: North America Medical Second Opinion Market Share – by Condition
8.1.2.2.2 United States: North America Medical Second Opinion Market Share – by Service Provider
8.1.2.3 Canada: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
8.1.2.3.1 Canada: North America Medical Second Opinion Market Share – by Condition
8.1.2.3.2 Canada: North America Medical Second Opinion Market Share – by Service Provider
8.1.2.4 Mexico: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
8.1.2.4.1 Mexico: North America Medical Second Opinion Market Share – by Condition
8.1.2.4.2 Mexico: North America Medical Second Opinion Market Share – by Service Provider
9.1 Overview
9.2 Market Initiative
9.3 Partnerships and Collaborations
10.1 Second Opinion International
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Elite Medical Services
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 The Cigna Group
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Helsana
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 WorldCare
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Vidal Health Insurance TPA Pvt Ltd
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 2nd.MD
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Axa SA
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Teladoc Health Inc
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Included Health, Inc.
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Products and Services
10.10.4 Financial Overview
10.10.5 SWOT Analysis
10.10.6 Key Developments
10.11 Royal Doctors
10.11.1 Key Facts
10.11.2 Business Description
10.11.3 Products and Services
10.11.4 Financial Overview
10.11.5 SWOT Analysis
10.11.6 Key Developments
11.1 About Us
11.2 List of Abbreviations
Table 1. North America Medical Second Opinion Market Segmentation
Table 2. North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
Table 3. North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Condition
Table 4. North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Service Provider
Table 5. North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Country
Table 6. United States: North America Medical Second Opinion Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Condition
Table 7. United States: North America Medical Second Opinion Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Service Provider
Table 8. Canada: North America Medical Second Opinion Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Condition
Table 9. Canada: North America Medical Second Opinion Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Service Provider
Table 10. Mexico: North America Medical Second Opinion Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Condition
Table 11. Mexico: North America Medical Second Opinion Market – Revenue and Forecast, 2021 – 2031(US$ Million) – by Service Provider
Table 12. List of Abbreviations
Figure 1. North America Medical Second Opinion Market Segmentation – Country
Figure 2. North America Medical Second Opinion Market – Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. North America Medical Second Opinion Market Revenue (US$ Million), 2021–2031
Figure 5. North America Medical Second Opinion Market Share (%) – by Condition (2023 and 2031)
Figure 6. Cancer: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 7. Orthopedic Disorders: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 8. Cardiac Disorders: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 9. Neurological Disorders: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 10. Nephrological Disorders: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 11. Hematological Blood Disorders: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 12. COPD: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 13. Organ Transplant: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 14. Others: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 15. North America Medical Second Opinion Market Share (%) – by Service Provider (2023 and 2031)
Figure 16. Hospitals: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 17. Health Insurance Companies: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 18. Online Services: North America Medical Second Opinion Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 19. North America Medical Second Opinion Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 20. United States: North America Medical Second Opinion Market – Revenue and Forecast, 2021– 2031 (US$ Million)
Figure 21. Canada: North America Medical Second Opinion Market – Revenue and Forecast, 2021– 2031 (US$ Million)
Figure 22. Mexico: North America Medical Second Opinion Market – Revenue and Forecast, 2021– 2031 (US$ Million)
E 1803, Panchshil Towers, Vagholi, Haveli, Pune- 412207, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Medical Second Opinion Market
